ASX 200 (XJO:ASX): Stock quote, stock chart, quotes, analysis, advice, financials and news for Index ASX 200 | Australian S.E.: XJO | Australian S.E.
A high-level overview of ASE Technology Holding Co., Ltd. (ASX) stock. View (ASX) real-time stock price, chart, news, analysis, analyst reviews and more.
For more information on NinjaTrader requirements, see:[/simpletab] [simpletab title=”Licensing and Terms”] 1). Your license allows use oncomputers you own (eg your desktop PC and a laptop). If you require installation on more than 2 computers, additional computer licenses can be purchased ...
0.00 (0.00) At Close DAY HIGH DAY LOW PREV CLOSE 52 WEEK RANGE 0.001 - 1.000 1 YR RETURN Overview News ASX 20 Chart Advanced Index Overview TheS&P/ASX 20 (XTL)is Australia's narrowest index and contains the ASX top 20 stocks by float-adjusted market capitalisation. The index is highly...
View full chart Distributions Tax Summary View full table Returns Average Annual Cumulative Calendar Year as of 1y3y5y10yIncept. Total Return (%)17.288.406.125.735.71 Benchmark (%)17.588.776.476.026.00 as of Total Return (%) Benchmark (%) ...
Share Price Analysis and Chart Enter the company code or Name for stock analysis: SOL - WASHINGTON H. SOUL PATTINSON AND CO. LIMITED FNArena Sector :Diversified Financials Year End:July GICS Industry Group :Diversified Financials Debt/EBITDA:-31.65 ...
Interactive Chart Performance Performance Technical ➕ Economic Data Dividend Log Bar 5D3MYTD1Y3Y5Y10Y20Y All Annualized Return % Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years Total Annual Return % Symbol ...
Nationwide Destination 2065 Fund Retirement price and volume Combination chart with 2 data series. Chart represents Nationwide Destination 2065 Fund Retirement price and volume over 1Y period The chart has 2 X axes displaying Time, and Time. The chart has 2 Y axes displaying symbol price, and sy...
Share Price Analysis and Chart Enter the company code or Name for stock analysis: PAR - PARADIGM BIOPHARMACEUTICALS LIMITED FNArena Sector :Pharmaceuticals & Biotech/Lifesciences Year End:June GICS Industry Group :Pharmaceuticals, Biotechnology & Life Sciences ...
The Directors have estimated 100% likelihood of the vesting criteria being achieved and as a result the full fair value of the options have been expensed. Set out below are summaries of options outstanding at the end of the financial year: 2022 Balance at Expired/ Balance at the start of ...